Page 9 - உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் மாதிரி பட்டியல்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roche purchases shares in tender offer for GenMark Diagnostics, Inc

Share: Basel, 22 April 2021 - Roche ((SIX: RO, ROG, OTCQX:RHHBY) and GenMark Diagnostics, Inc. today announced that Roche s wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) at a price of USD 24.05 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 21 April 2021 and was not extended. Roche has been advised by Citibank, N.A., the depositary for the tender offer, that a total of approximately 61,201,761 shares of GenMark s common stock were validly tendered and not validly withdrawn in the tender offer (excluding shares tendered by notice of guaranteed delivery for which certificates have not yet been received ), which represent approximately 82.89% of the total number of shares of GenMark s common stock outstanding.

United statesNathalie meetzDaniel grotzkyThomas schineckerPatrick barthKarsten kleineGeronimo acquisition corpGenmark diagnostics incExchange commissionSecurities exchangeRoche groupPharmaceuticals industryRoche group media relationsGenmark diagnosticsGeronimo acquisitionEastern time

Roche reports solid results in the first quarter of 2021

Commenting on the Group’s performance in the first quarter, Roche CEO Severin Schwan said: “In 2021, Roche remains strongly committed to the fight against COVID-19. The uptake of our recently introduced diagnostic tests and medicines remains strong, while we continue to see the expected impact from biosimilars on sales of our established medicines. Our broad product pipeline keeps making good progress. I am particularly pleased about the highly encouraging study results of our immunotherapy Tecentriq in early lung cancer and of faricimab in ophthalmology. The upcoming acquisition of GenMark underlines our commitment to help control infectious diseases and antibiotic resistance. Based on the results of the first quarter of 2021, we confirm the outlook for the full year.”

United statesNathalie meetzDaniel grotzkyActemra roactemraMabthera rituxanPatrick barthGazyva gazyvaroKarsten kleinePathology labEuropean commissionDiagnostics divisionInternational regionMolecular labCore labPharmaceuticals divisionRoche group

Roche : Q1 2021 Investor update | MarketScreener

Group sales increase 3% 1 at constant exchange rates (CER); 1% decline in Swiss francs, as a result of the appreciation of the Swiss franc Pharmaceuticals Division sales: As expected, significant impact from biosimilars (CHF -1.6 billion) Base effect from the strong first quarter 2020 (negative impact of the pandemic only since April 2020) Overall, this results in a 9% decline in sales. Diagnostics Division sales: Roche s contributions to the fight against the COVID-19 pandemic in the first quarter: SARS-CoV-2 Rapid Antigen Test Nasal to quickly identify people with the highest risk to be infectious (using simple nasal swabs) receives CE mark and special approvals for self-testing in several countries

United statesSeverin schwanMabthera rituxanActemra roactemraDiagnostics divisionInternational regionMolecular labPharmaceuticals divisionRoche groupPharmaceuticals industryAntigen test nasalNorth americaLatin americaGenmark diagnosticsQuarter salesWorld health organization model lists

F Hoffmann-La Roche Ltd: Roche reports solid results in the first quarter of 2021

F Hoffmann-La Roche Ltd: Roche reports solid results in the first quarter of 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNathalie meetzDaniel grotzkyMabthera rituxanGazyva gazyvaroSeverin schwanActemra roactemraPatrick barthKarsten kleinePathology labEuropean commissionDiagnostics divisionInternational regionMolecular labCore labPharmaceuticals division

Roche reports solid results in the first quarter of 2021

Roche reports solid results in the first quarter of 2021
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.